204 related articles for article (PubMed ID: 18267033)
1. Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo.
Jang JY; Choi Y; Jeon YK; Kim CW
Breast Cancer Res; 2008; 10(1):R11. PubMed ID: 18267033
[TBL] [Abstract][Full Text] [Related]
2. Short-hairpin RNA-induced suppression of adenine nucleotide translocase-2 in breast cancer cells restores their susceptibility to TRAIL-induced apoptosis by activating JNK and modulating TRAIL receptor expression.
Jang JY; Jeon YK; Choi Y; Kim CW
Mol Cancer; 2010 Sep; 9():262. PubMed ID: 20875141
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus adenine nucleotide translocator-2 shRNA effectively induces apoptosis and enhances chemosensitivity by the down-regulation of ABCG2 in breast cancer stem-like cells.
Jang JY; Kim MK; Jeon YK; Joung YK; Park KD; Kim CW
Exp Mol Med; 2012 Apr; 44(4):251-9. PubMed ID: 22198296
[TBL] [Abstract][Full Text] [Related]
4. Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells.
Jang JY; Jeon YK; Kim CW
BMC Cancer; 2010 Jul; 10():391. PubMed ID: 20650008
[TBL] [Abstract][Full Text] [Related]
5. The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131.
Choi Y; Lee HW; Lee J; Jeon YH
BMC Cancer; 2013 Mar; 13():143. PubMed ID: 23522027
[TBL] [Abstract][Full Text] [Related]
6. Combined RNA interference of adenine nucleotide translocase-2 and ganciclovir therapy in hepatocellular carcinoma.
Kim JE; Hwang MH; Lee HW; Lee SW; Lee J; Ahn BC
Nucl Med Biol; 2013 Nov; 40(8):987-93. PubMed ID: 24054501
[TBL] [Abstract][Full Text] [Related]
7. ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells.
Baik SH; Lee J; Lee YS; Jang JY; Kim CW
Exp Mol Med; 2016 Mar; 48(3):e222. PubMed ID: 27012708
[TBL] [Abstract][Full Text] [Related]
8. Chemosensitization by knockdown of adenine nucleotide translocase-2.
Le Bras M; Borgne-Sanchez A; Touat Z; El Dein OS; Deniaud A; Maillier E; Lecellier G; Rebouillat D; Lemaire C; Kroemer G; Jacotot E; Brenner C
Cancer Res; 2006 Sep; 66(18):9143-52. PubMed ID: 16982757
[TBL] [Abstract][Full Text] [Related]
9. ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma.
Jang JY; Lee YS; Jeon YK; Lee K; Jang JJ; Kim CW
Exp Mol Med; 2013 Jan; 45(1):e3. PubMed ID: 23306701
[TBL] [Abstract][Full Text] [Related]
10. Targeting Adenine Nucleotide Translocase-2 (ANT2) to Overcome Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer.
Jang JY; Kim YG; Nam SJ; Keam B; Kim TM; Jeon YK; Kim CW
Mol Cancer Ther; 2016 Jun; 15(6):1387-96. PubMed ID: 26883272
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of adenine nucleotide translocase 1 (ANT1) induces apoptosis and tumor regression in vivo.
Jang JY; Choi Y; Jeon YK; Aung KC; Kim CW
BMC Cancer; 2008 Jun; 8():160. PubMed ID: 18522758
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of in vivo antitumor effects of ANT2 shRNA delivered using PEI and ultrasound with microbubbles.
Park DH; Jung BK; Lee YS; Jang JY; Kim MK; Lee JK; Park H; Seo J; Kim CW
Gene Ther; 2015 Apr; 22(4):325-32. PubMed ID: 25588739
[TBL] [Abstract][Full Text] [Related]
13. ANT2 suppression by shRNA may be able to exert anticancer effects in HCC further by restoring SOCS1 expression.
Jang JY; Jeon YK; Lee CE; Kim CW
Int J Oncol; 2013 Feb; 42(2):574-82. PubMed ID: 23242177
[TBL] [Abstract][Full Text] [Related]
14. The hepatoprotective effects of adenine nucleotide translocator-2 against aging and oxidative stress.
Kim HS; Je JH; Son TG; Park HR; Ji ST; Pokharel YR; Jeon HM; Kang KW; Kang HS; Chang SC; Kim HS; Chung HY; Lee J
Free Radic Res; 2012 Jan; 46(1):21-9. PubMed ID: 22034909
[TBL] [Abstract][Full Text] [Related]
15. Repression of the human adenine nucleotide translocase-2 gene in growth-arrested human diploid cells: the role of nuclear factor-1.
Luciakova K; Barath P; Poliakova D; Persson A; Nelson BD
J Biol Chem; 2003 Aug; 278(33):30624-33. PubMed ID: 12777383
[TBL] [Abstract][Full Text] [Related]
16. Apigenin sensitizes prostate cancer cells to Apo2L/TRAIL by targeting adenine nucleotide translocase-2.
Oishi M; Iizumi Y; Taniguchi T; Goi W; Miki T; Sakai T
PLoS One; 2013; 8(2):e55922. PubMed ID: 23431365
[TBL] [Abstract][Full Text] [Related]
17. Adenine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism.
Chevrollier A; Loiseau D; Reynier P; Stepien G
Biochim Biophys Acta; 2011 Jun; 1807(6):562-7. PubMed ID: 20950584
[TBL] [Abstract][Full Text] [Related]
18. ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.
Jiang Q; Zhang H; Zhang P
J Exp Clin Cancer Res; 2011 May; 30(1):60. PubMed ID: 21595884
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial ncRNA targeting induces cell cycle arrest and tumor growth inhibition of MDA-MB-231 breast cancer cells through reduction of key cell cycle progression factors.
Fitzpatrick C; Bendek MF; Briones M; Farfán N; Silva VA; Nardocci G; Montecino M; Boland A; Deleuze JF; Villegas J; Villota C; Silva V; Lobos-Gonzalez L; Borgna V; Barrey E; Burzio LO; Burzio VA
Cell Death Dis; 2019 May; 10(6):423. PubMed ID: 31142736
[TBL] [Abstract][Full Text] [Related]
20. [What is the specific role of ANT2 in cancer cells?].
Chevrollier A; Loiseau D; Stepien G
Med Sci (Paris); 2005 Feb; 21(2):156-61. PubMed ID: 15691486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
